Skip Navigation

European Heart Journal 1994 15(Supplement D):63-67; doi:10.1093/eurheartj/15.suppl_D.63
Copyright © 1994 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Paul, M.
Right arrow Articles by Böhm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, M.
Right arrow Articles by Böhm, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 The European Society of Cardiology

Activation of the Renin-Angiotensin System in Heart Failure and Hypertrophy—Studies in Human Hearts and Transgenic Rats

M. Paul*,, Y. M. Pinto{dagger}, H. Schunkert{ddagger}, D. Ganten* and M. Böhm§

* German Institute for High Blood Pressure Research and Max-Delbrück Center for Molecular Medicine Berlin, Germany
{dagger} Dept. of Pharmacology and Clinical Pharmacology, University of Groningen The Netherlands
{ddagger} Department of Medicine, University of Regensburg Regensburg, Germany
§ Third Department of Medicine, University of Köln Köln, Germany

Correspondence: Martin Paul, MD, Max-Delbrock-Center for Molecular Medicine, Hypertension Group, Robert-Rössle-Straβe 10, 13125 Berlin, Germany

Numerous in vitro studies have demonstrated that angiotensin II has distinctive cellular effects in the cardiovascular system, independent from its effects on blood pressure. These have led to the hypothesis that activation of the angiotensin system in the heart could be of functional relevance for the adaptive processes in several cardiovascular disorders, such as cardiac hypertrophy and heart failure. This concept has been supported by clinical studies showing the beneficial effects of blockers of the system such as angiotensin converting enzyme (ACE) inhibitors in these circumstances. In order to study the regulation of gene expression of renin angiotensin system components in cardiac disorders we have performed two studies. First, we investigated the gene expression of ACE in human heart failure. Results showed that the enzyme is activated locally in this condition, Supporting previous studies in animals. Second, in a different approach, we asked whether the selective activation of the renin angiotensin system in the hearts of transgenic rats expressing an additional renin gene leads to the development of pathological changes in the cardiovascular system. The results of this study demonstrated that the transgenic animals developed cardiac hypertrophy and heart failure independent of the increase in blood pressure seen in these rats. Taken together, these studies provide further evidence for the functional role of local angiotensin systems in the heart.

Key Words: Angiotensin converting enzyme • gene expression • transgenic rats • human heart


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.